Cargando…
Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens
Isothermal nucleic acid amplification methods can potentially shorten the amount of time required to diagnose influenza. We developed and evaluated a novel isothermal nucleic acid amplification method, RT-SIBA to rapidly detect and differentiate between influenza A and B viruses in a single reaction...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127616/ https://www.ncbi.nlm.nih.gov/pubmed/29778563 http://dx.doi.org/10.1016/j.diagmicrobio.2018.04.006 |
_version_ | 1783516398717239296 |
---|---|
author | Elf, Sonja Auvinen, Pauliina Jahn, Lisa Liikonen, Karoliina Sjöblom, Solveig Saavalainen, Päivi Mäki, Minna Eboigbodin, Kevin E. |
author_facet | Elf, Sonja Auvinen, Pauliina Jahn, Lisa Liikonen, Karoliina Sjöblom, Solveig Saavalainen, Päivi Mäki, Minna Eboigbodin, Kevin E. |
author_sort | Elf, Sonja |
collection | PubMed |
description | Isothermal nucleic acid amplification methods can potentially shorten the amount of time required to diagnose influenza. We developed and evaluated a novel isothermal nucleic acid amplification method, RT-SIBA to rapidly detect and differentiate between influenza A and B viruses in a single reaction tube. The performance of the RT-SIBA Influenza assay was compared with two established RT-PCR methods. The sensitivities of the RT-SIBA, RealStar RT-PCR, and CDC RT-PCR assays for the detection of influenza A and B viruses in the clinical specimens were 98.8%, 100%, and 89.3%, respectively. All three assays demonstrated a specificity of 100%. The average time to positive result was significantly shorter with the RT-SIBA Influenza assay (<20 min) than with the two RT-PCR assays (>90 min). The method can be run using battery-operated, portable devices with a small footprint and therefore has potential applications in both laboratory and near-patient settings. |
format | Online Article Text |
id | pubmed-7127616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71276162020-04-08 Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens Elf, Sonja Auvinen, Pauliina Jahn, Lisa Liikonen, Karoliina Sjöblom, Solveig Saavalainen, Päivi Mäki, Minna Eboigbodin, Kevin E. Diagn Microbiol Infect Dis Article Isothermal nucleic acid amplification methods can potentially shorten the amount of time required to diagnose influenza. We developed and evaluated a novel isothermal nucleic acid amplification method, RT-SIBA to rapidly detect and differentiate between influenza A and B viruses in a single reaction tube. The performance of the RT-SIBA Influenza assay was compared with two established RT-PCR methods. The sensitivities of the RT-SIBA, RealStar RT-PCR, and CDC RT-PCR assays for the detection of influenza A and B viruses in the clinical specimens were 98.8%, 100%, and 89.3%, respectively. All three assays demonstrated a specificity of 100%. The average time to positive result was significantly shorter with the RT-SIBA Influenza assay (<20 min) than with the two RT-PCR assays (>90 min). The method can be run using battery-operated, portable devices with a small footprint and therefore has potential applications in both laboratory and near-patient settings. Elsevier Inc. 2018-09 2018-04-18 /pmc/articles/PMC7127616/ /pubmed/29778563 http://dx.doi.org/10.1016/j.diagmicrobio.2018.04.006 Text en © 2018 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Elf, Sonja Auvinen, Pauliina Jahn, Lisa Liikonen, Karoliina Sjöblom, Solveig Saavalainen, Päivi Mäki, Minna Eboigbodin, Kevin E. Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens |
title | Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens |
title_full | Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens |
title_fullStr | Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens |
title_full_unstemmed | Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens |
title_short | Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens |
title_sort | development and evaluation of a rapid nucleic acid amplification method to detect influenza a and b viruses in human respiratory specimens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127616/ https://www.ncbi.nlm.nih.gov/pubmed/29778563 http://dx.doi.org/10.1016/j.diagmicrobio.2018.04.006 |
work_keys_str_mv | AT elfsonja developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens AT auvinenpauliina developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens AT jahnlisa developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens AT liikonenkaroliina developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens AT sjoblomsolveig developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens AT saavalainenpaivi developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens AT makiminna developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens AT eboigbodinkevine developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens |